Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
S Slavin, E Naparstek, A Nagler… - Experimental …, 1995 - europepmc.org
Allogeneic bone marrow transplantation (BMT) is the treatment of choice for hematologic
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
[引用][C] Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
S SLAVIN - Exp Hematol, 1995 - cir.nii.ac.jp
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor
peripheral blood lymphocytes. | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
peripheral blood lymphocytes. | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
S Slavin, E Naparstek, A Nagler, A Ackerstein… - Experimental …, 1995 - cris.bgu.ac.il
Allogeneic bone marrow transplantation (BMT) is the treatment of choice for hematologic
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
S Slavin, E Naparstek, A Nagler… - Experimental …, 1995 - pubmed.ncbi.nlm.nih.gov
Allogeneic bone marrow transplantation (BMT) is the treatment of choice for hematologic
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
malignancies resistant to conventional chemotherapy and for patients who are at high risk …
[引用][C] Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation wit donor peripheral blood lymphocytes
S SLAVIN - Exp Hematol, 1995 - ci.nii.ac.jp
CiNii 論文 - Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation
wit donor peripheral blood lymphocytes CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
wit donor peripheral blood lymphocytes CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
[引用][C] Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
S SLAVIN - Exp Hematol, 1995 - cir.nii.ac.jp
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor
peripheral blood lymphocytes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
peripheral blood lymphocytes | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[引用][C] Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes
S SLAVIN - Exp Hematol., 1995 - ci.nii.ac.jp
CiNii 論文 - Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation
with donor peripheral blood lymphocytes CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
with donor peripheral blood lymphocytes CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …